2Davis R, Peters DV, McTavish D. Valproic acid: a reappraisal of its pharmacological properties and clinical efficacy in epilepsy. Drugs 1994; 47: 332-72. 被引量：1
4Yu LY, Qu ZP, Hong Z, Zhang JJ. Syrup sodium valproate in treatment of epilepsy relationship of dose, blood level and effect. Clin Pharm 1995; 4: 4-7. 被引量：1
5Hou Q, Qu ZP, Yu LY, Zhang JH, Wu YL, Zhang H.Pharmacokinefics, serum concentration and therapy efficacy of enteric-coated tablet and sustained release tablet of valproate. Chin J Neurol Psych 1993; 26: 165. 被引量：1
6Cloyd JC, Fisher JH, Kriel RL, Kraus DM. Valproic acid pharmacokinetics in children. IV: Effects of age and antiepileptic drugs on protein binding and intrinsic clearance.Clin Pharmacol Ther 1993; 53: 22-9. 被引量：1
7USC*PACK [computer program]. Version 10.7. Los Angeles.CA: Laboratory of Applied Pharmacokinetics, University of Southern California. School of Medicine: USC*PACK P.C.Collection Clinical Research Programs. 1995. 被引量：1
8Charpiat B, Breant V, Pivot-Dumarest C, Maire P, Jelliffe RW. Prediction of Future Serum Concentrations with Bayesian Fitted Pharmacokinetic Models: Results with Data Collected by Nurses Versus Trained Pharmacy Residents. Ther Drug Monit 1994; 16: 166-73. 被引量：1
9Jelliffe RW. The USC*PACK PC User Manual. The program NPEM2 (version 3.0) from the Laboratory of Applied Pharmacokinetics, University of Southern California School of Medicine, CSC 134-B, 2250 Alcazar St, Los Angeles CA 90033. 1995. 被引量：1
10Sun H, Fadiran EO, Jones CD, Lesko L, Hung SM, Higgins K, et al. Population pharmacokinetics: a regulatory perspective. Clin Pharmacokinet 1999; 37: 41-58. 被引量：1
5Gallagher RM, Bird KA, Maso JR, et al. Adverse drug reactions casusing admission to a paediatric hospital: a pilot study[J]. J Clin Pharm Ther, 2011, 36(2) :194-199. 被引量：1
6Gallagher RM,Bird KA,Mason JR. Adverse drug reactions casusing admission to a paediatric hospital:a pilot study[J].Journal of Clinical Pharmacy and therapeutics,2011,(02):194.doi:10.1111/j.1365-2710.2010.01194.x. 被引量：1
8Hamed SA, Abdella MM. The risk of asymptomatic hy-perammonemia in children with idiopathic epilepsy treatedwith valproate : relationship to blood carnitine status [J].Epilepsy Res,2009 ,86(1) :32-41. 被引量：1
